Herceptin breast cancer drug

Numéro d’image : 11521477
Herceptin breast cancer drug
Herceptin breast cancer drug. Molecular model of the drug Herceptin (trastuzumab). Overabundance of HER2,a receptor found on some breast cancer cells,makes them faster-growing and more likely to spread. Herceptin blocks these receptors by binding to them,greatly improving the chances of curing the cancer. Around 20% of breast cancers have HER2 over-expression,and are thus viable targets for the drug. In the UK in 2005,it was announced that all women with early breast cancer would be tested to see if their tumours would be receptive to Herceptin therapy. However,the decision has been controversial due to the divided medical opinions surrounding the effectiveness of the drug
Licence : Droits gérés
Crédit: Science Photo Library / Winter, Dr. Mark J.
Taille de l’image : 6591 px × 5091 px
Model Release : Non requis
Property Release : Non requis
Restrictions : -

Prix pour cette image À partir de 45 €

Produit vendu
(Calendrier, Carte postale, Carte de vœux, Impression sur textile, Packaging etc)
À partir de 45 €
Usage commercial
(Affichage, Annonce presse, Annonce TV, Carte, Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 45 €
Éditorial
(Digital, Journal, Livre, Livre pratique, Magazine, Télévision etc)
À partir de 60 €
Usage non-commercial
(Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 120 €

Mots clés

;